PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Reveals whether the business's core operations generate sufficient cash to cover expenses, fund growth, and return capital to shareholders. Sustainable free cash flow is often a key indicator of long-term value creation.
-0.17
Negative OCF/share indicates operating outflows – a Benjamin Graham red flag. Investigate if short-term timing issues or fundamental weaknesses cause the cash drain.
-0.17
Negative FCF/share suggests outflows after capex. Benjamin Graham would see this as a warning unless it’s a strategic growth phase.
No Data
No Data available this quarter, please select a different quarter.
0.78
Below 1.0 – Earnings may outstrip actual OCF. Howard Marks would caution about potential accrual or earnings quality issues.
No Data
No Data available this quarter, please select a different quarter.